Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 363

1.

Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors.

Ramos-Vara JA, Miller MA, Boucher M, Roudabush A, Johnson GC.

Vet Pathol. 2003 Jan;40(1):55-62.

PMID:
12627713
[PubMed - indexed for MEDLINE]
Free Article
2.

Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.

Parker DC, Folpe AL, Bell J, Oliva E, Young RH, Cohen C, Amin MB.

Am J Surg Pathol. 2003 Jan;27(1):1-10.

PMID:
12502922
[PubMed - indexed for MEDLINE]
3.

Uroplakin-III to distinguish primary vulvar Paget disease from Paget disease secondary to urothelial carcinoma.

Brown HM, Wilkinson EJ.

Hum Pathol. 2002 May;33(5):545-8.

PMID:
12094381
[PubMed - indexed for MEDLINE]
4.

Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.

Bassily NH, Vallorosi CJ, Akdas G, Montie JE, Rubin MA.

Am J Clin Pathol. 2000 Mar;113(3):383-8.

PMID:
10705819
[PubMed - indexed for MEDLINE]
Free Article
5.

[Uroplakin III, a specific membrane protein of urothelial umbrella cells, as a histological markers for metastatic transitional cell carcinomas].

Moll R, Laufer J, Wu XR, Sun TT.

Verh Dtsch Ges Pathol. 1993;77:260-5. German.

PMID:
7511294
[PubMed - indexed for MEDLINE]
6.

Uroplakin expression in the urothelial tumors of cows.

Ambrosio V, Borzacchiello G, Bruno F, Galati P, Roperto F.

Vet Pathol. 2001 Nov;38(6):657-60.

PMID:
11732799
[PubMed - indexed for MEDLINE]
Free Article
7.

Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.

Tamas EF, Epstein JI.

Am J Surg Pathol. 2007 Mar;31(3):390-7.

PMID:
17325480
[PubMed - indexed for MEDLINE]
8.

Coordinate expression of cytokeratins 7 and 20 in feline and canine carcinomas.

Espinosa de los Monteros A, Fernández A, Millán MY, Rodríguez F, Herráez P, Martín de las Mulas J.

Vet Pathol. 1999 May;36(3):179-90.

PMID:
10332826
[PubMed - indexed for MEDLINE]
Free Article
9.

Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?

Buchumensky V, Klein A, Zemer R, Kessler OJ, Zimlichman S, Nissenkorn I.

J Urol. 1998 Dec;160(6 Pt 1):1971-4.

PMID:
9817302
[PubMed - indexed for MEDLINE]
10.

Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.

Riedel I, Czernobilsky B, Lifschitz-Mercer B, Roth LM, Wu XR, Sun TT, Moll R.

Virchows Arch. 2001 Feb;438(2):181-91.

PMID:
11253121
[PubMed - indexed for MEDLINE]
11.

Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer.

Gaisa NT, Braunschweig T, Reimer N, Bornemann J, Eltze E, Siegert S, Toma M, Villa L, Hartmann A, Knuechel R.

Virchows Arch. 2011 Mar;458(3):301-12. doi: 10.1007/s00428-010-1017-2. Epub 2010 Dec 7.

PMID:
21136076
[PubMed - indexed for MEDLINE]
12.

Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.

Moll R, Achtstätter T, Becht E, Balcarova-Ständer J, Ittensohn M, Franke WW.

Am J Pathol. 1988 Jul;132(1):123-44.

PMID:
2456018
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.

Samaratunga H, Khoo K.

Histopathology. 2004 Jul;45(1):55-64.

PMID:
15228444
[PubMed - indexed for MEDLINE]
14.

[Coordinated expression of cytokeratin 7 and 20 in transitional carcinoma of the bladder: diagnostic usefulness].

Cid Mouteira P, Ortíz Rey JA, Antón Badiola I, San Miguel Fraile P, Alvarez Alvarez C, Zungri Telo E, de la Fuente Buceta A.

Actas Urol Esp. 2002 Apr;26(4):279-84. Spanish.

PMID:
12090187
[PubMed - indexed for MEDLINE]
15.

Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.

Feil G, Maurer S, Nagele U, Krug J, Bock C, Sievert KD, Stenzl A.

Eur Urol. 2008 May;53(5):1066-72. Epub 2007 Oct 23.

PMID:
17980954
[PubMed - indexed for MEDLINE]
16.

Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis.

Soslow RA, Rouse RV, Hendrickson MR, Silva EG, Longacre TA.

Int J Gynecol Pathol. 1996 Jul;15(3):257-65.

PMID:
8811388
[PubMed - indexed for MEDLINE]
18.

Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study.

Sim SJ, Ro JY, Ordonez NG, Park YW, Kee KH, Ayala AG.

Mod Pathol. 1999 Apr;12(4):351-5.

PMID:
10229498
[PubMed - indexed for MEDLINE]
19.

Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis.

Jiang J, Ulbright TM, Younger C, Sanchez K, Bostwick DG, Koch MO, Eble JN, Cheng L.

Arch Pathol Lab Med. 2001 Jul;125(7):921-3.

PMID:
11419977
[PubMed - indexed for MEDLINE]
20.

Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.

Christoph F, Müller M, Schostak M, Soong R, Tabiti K, Miller K.

Urology. 2004 Jul;64(1):157-61.

PMID:
15245962
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk